Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25579667

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

Author
PENEL, N1 2 ; ITALIANO, A3 ; BOMPAS, E10 ; BAY, J. O11 ; DUFFAUD, F12 ; GUILLEMET, C13 ; BLAY, J. Y4 ; RAY-COQUARD, I4 ; CHAIGNEAU, L5 ; DELCAMBRE, C6 ; ROBIN, Y. M1 ; BUI, B3 ; BERTUCCI, F7 ; ISAMBERT, N8 ; CUPISSOL, D9
[1] Sarcoma Unit, Department of General Oncology, Centre Oscar Lambret, Lille, France
[2] Epidemiology and Modelisation of Chronic Illness Research Unit (EA 2694), Lille University, Lille, France
[3] Department of Medical Oncology, Institut Bergonié, Bordeaux, France
[4] Department of Medical Oncology, Centre Leon Bérard, Lyon, France
[5] Department of Medical Oncology, Hopital Universitaire Jean Minjoz, Besançon, France
[6] Department of Medical Oncology, Centre François Baclesse, Caen, France
[7] Department of Medical Oncology, Institut Paoli-Calmette, Marseille, France
[8] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France
[9] Department of Medical Oncology, Centre Val d'Aurelle, Montpellier, France
[10] Department of Medical Oncology, Centre René Gauducheau, Nantes, France
[11] Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France
[12] Department of Medical Oncology, Hopital de la Timone, Marseille, France
[13] Department of Medical Oncology, Centre Henri Becquerel, Rennes, France
French Sarcoma Group (GSF/GETO), France
Source

Annals of oncology. 2012, Vol 23, Num 2, pp 517-523, 7 p ; ref : 33 ref

ISSN
0923-7534
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Oxford University Press, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
angiosarcoma doxorubicin metastases prognostic factors surgery weekly paclitaxel
Keyword (fr)
Angiosarcome Anticancéreux Chirurgie Doxorubicine Métastase Paclitaxel Pronostic Protocole thérapeutique Rythme administration Sarcome Stade avancé Traitement Anthracyclines Antimitotique Cancer DNA topoisomerase (ATP-hydrolysing) Dérivé du taxane Enzyme Inhibiteur de la topoisomérase II Inhibiteur enzyme Isomerases Pathologie de l'appareil circulatoire Pathologie des vaisseaux sanguins Tumeur maligne
Keyword (en)
Angiosarcoma Antineoplastic agent Surgery Doxorubicin Metastasis Paclitaxel Prognosis Therapeutic protocol Administration schedule Sarcoma Advanced stage Treatment Anthracyclins Antimitotic Cancer DNA topoisomerase (ATP-hydrolysing) Taxane derivatives Enzyme Topoisomerase II inhibitor Enzyme inhibitor Isomerases Cardiovascular disease Vascular disease Malignant tumor
Keyword (es)
Angiosarcoma Anticanceroso Cirugía Doxorubicina Metástasis Paclitaxel Pronóstico Protocolo terapéutico Ritmo administración Sarcoma Estadio avanzado Tratamiento Antraciclinas Antimitótico Cáncer DNA topoisomerase (ATP-hydrolysing) Taxane derivado Enzima Inhibidor topoisomerase II Inhibidor enzima Isomerases Aparato circulatorio patología Vaso sanguíneo patología Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
25579667

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web